Evaluation of chitosan nanoformulations as potent anti-HIV therapeutic systems.

[1]  Y. Kuo,et al.  Cationic solid lipid nanoparticles with primary and quaternary amines for release of saquinavir and biocompatibility with endothelia. , 2013, Colloids and surfaces. B, Biointerfaces.

[2]  Jianping Zhou,et al.  Somatostatin receptor-mediated tumor-targeting drug delivery using octreotide-PEG-deoxycholic acid conjugate-modified N-deoxycholic acid-O, N-hydroxyethylation chitosan micelles. , 2012, Biomaterials.

[3]  U. Krishnan,et al.  Investigation on the stability of saquinavir loaded liposomes: implication on stealth, release characteristics and cytotoxicity. , 2012, International journal of pharmaceutics.

[4]  S. Arora,et al.  Novel drug delivery approaches on antiviral and antiretroviral agents , 2012, Journal of advanced pharmaceutical technology & research.

[5]  Lingrong Liu,et al.  Interaction of bovine serum albumin with self-assembled nanoparticles of 6-O-cholesterol modified chitosan. , 2012, Colloids and surfaces. B, Biointerfaces.

[6]  A. Mandal,et al.  Chitosan nanoparticles as a dual growth factor delivery system for tissue engineering applications. , 2011, International journal of pharmaceutics.

[7]  L. Keawchaoon,et al.  Preparation, characterization and in vitro release study of carvacrol-loaded chitosan nanoparticles. , 2011, Colloids and surfaces. B, Biointerfaces.

[8]  S. Nair,et al.  Preparation, characterization, in vitro drug release and biological studies of curcumin loaded dextran sulphate–chitosan nanoparticles , 2011 .

[9]  R. Chen,et al.  The storage stability of chitosan/tripolyphosphate nanoparticles in a phosphate buffer , 2011 .

[10]  Q. Ping,et al.  Novel pH-sensitive chitosan-derived micelles loaded with paclitaxel , 2010 .

[11]  A. Maharramov,et al.  SYNTHESIS AND CHARACTERIZATION OF BIODEGRADABLE CHITOSAN BEADS AS NANO-CARRIERS FOR LOCAL DELIVERY OF SATRANIDAZOLE , 2010 .

[12]  X. Wu,et al.  Nanotechnology applications for improved delivery of antiretroviral drugs to the brain. , 2010, Advanced drug delivery reviews.

[13]  N. K. Jain,et al.  Non-polymeric nano-carriers in HIV/AIDS drug delivery and targeting. , 2010, Advanced drug delivery reviews.

[14]  B. Sarmento,et al.  Nanotechnology-based systems for the treatment and prevention of HIV/AIDS. , 2010, Advanced drug delivery reviews.

[15]  R. Misra,et al.  Controlled and extended drug release behavior of chitosan-based nanoparticle carrier. , 2010, Acta biomaterialia.

[16]  Sanjay K. Jain,et al.  Design and development of ligand-appended polysaccharidic nanoparticles for the delivery of oxaliplatin in colorectal cancer. , 2010, Nanomedicine : nanotechnology, biology, and medicine.

[17]  Ick Chan Kwon,et al.  Targeted delivery of low molecular drugs using chitosan and its derivatives. , 2010, Advanced drug delivery reviews.

[18]  R. Zeng,et al.  Synthesis, nanosizing and in vitro drug release of a novel anti-HIV polymeric prodrug: chitosan-O-isopropyl-5'-O-d4T monophosphate conjugate. , 2010, Bioorganic & medicinal chemistry.

[19]  V. Mourya,et al.  Trimethyl chitosan and its applications in drug delivery , 2009, Journal of materials science. Materials in medicine.

[20]  N. Zhong,et al.  Induction of Th1-Type Immune Response by Chitosan Nanoparticles Containing Plasmid DNA Encoding House Dust Mite Allergen Der p 2 for Oral Vaccination in Mice , 2009, Cellular and Molecular Immunology.

[21]  V. Jain,et al.  Preparation and performance evaluation of saquinavir laden cationic submicron emulsions , 2009, Drug delivery.

[22]  Y. Kuo,et al.  Entrapment and release of saquinavir using novel cationic solid lipid nanoparticles. , 2008, International journal of pharmaceutics.

[23]  Hong Ding,et al.  Bioconjugated quantum rods as targeted probes for efficient transmigration across an in vitro blood-brain barrier. , 2008, Bioconjugate chemistry.

[24]  Tushar K. Vyas,et al.  Improved oral bioavailability and brain transport of Saquinavir upon administration in novel nanoemulsion formulations. , 2008, International journal of pharmaceutics.

[25]  N. K. Jain,et al.  Targeting potential and anti-HIV activity of lamivudine loaded mannosylated poly (propyleneimine) dendrimer. , 2007, Biochimica et biophysica acta.

[26]  R. Gao,et al.  Porcine interleukin-2 gene encapsulated in chitosan nanoparticles enhances immune response of mice to piglet paratyphoid vaccine. , 2007, Comparative immunology, microbiology and infectious diseases.

[27]  Mansoor M. Amiji,et al.  Intracellular Delivery of Saquinavir in Biodegradable Polymeric Nanoparticles for HIV/AIDS , 2006, Pharmaceutical Research.

[28]  A. Rabson,et al.  Synthesis of poly(ethylene glycol)-based saquinavir prodrug conjugates and assessment of release and anti-HIV-1 bioactivity using a novel protease inhibition assay. , 2004, Bioconjugate chemistry.

[29]  P. Tengvall,et al.  Blood protein adsorption onto chitosan. , 2002, Biomaterials.

[30]  G. Ponchel,et al.  Combined hydroxypropyl-beta-cyclodextrin and poly(alkylcyanoacrylate) nanoparticles intended for oral administration of saquinavir. , 2001, International journal of pharmaceutics.

[31]  Neff Walker,et al.  The global impact of HIV/AIDS , 2001, Nature.

[32]  C. Birch,et al.  Effect of protease inhibitors on HIV-1 maturation and infectivity. , 2000, Antiviral research.

[33]  Li,et al.  Transport, metabolism and elimination mechanisms of anti-HIV agents. , 1999, Advanced drug delivery reviews.

[34]  J. Silverman,et al.  Saquinavir, an HIV protease inhibitor, is transported by P-glycoprotein. , 1998, The Journal of pharmacology and experimental therapeutics.

[35]  D. Roden,et al.  The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors. , 1998, The Journal of clinical investigation.

[36]  D. Shen,et al.  Enzyme-catalyzed processes of first-pass hepatic and intestinal drug extraction. , 1997, Advanced drug delivery reviews.

[37]  Bradley Efron,et al.  The Effect of High-Dose Saquinavir on Viral Load and CD4+ T-Cell Counts in HIV-Infected Patients , 1996, Annals of Internal Medicine.

[38]  E. Pretzer,et al.  Inhibition of HIV-1 infection of macrophages and H9 cells by free or liposome-encapsulated L-689,502, an inhibitor of the viral protease , 1995 .

[39]  F. H. Yin,et al.  Mutagenesis of protease cleavage sites in the human immunodeficiency virus type 1 gag polyprotein , 1991, Journal of virology.

[40]  V. Marchesi,et al.  Chemical characterization and surface orientation of the major glycoprotein of the human erythrocyte membrane. , 1972, Proceedings of the National Academy of Sciences of the United States of America.